Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndrome

Kelly S. Chien, Kunhwa Kim, Graciela M. Nogueras-Gonzalez, Gautam Borthakur, Kiran Naqvi, Naval G. Daver, Guillermo Montalban-Bravo, Jorge E. Cortes, Courtney D. DiNardo, Elias Jabbour, Yesid Alvarado, Michael Andreeff, Prithviraj Bose, Nitin Jain, Tapan M. Kadia, Xuelin Huang, Kimberly B. Sheppard, Cheri Klingner-Winton, Sherry A. Pierce, Xiao Qin DongKelly A. Soltysiak, Hagop M. Kantarjian, Guillermo Garcia-Manero

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences